Bergstein Ivan

Avg. Two Year Performance

(27%) Avg. Purchase Return
(13%) Compound
(4%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return16%34%41%(22%)(27%)
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return< 1%(3%)2%(6%)(4%)
Sale Success Rate2 of 92 of 94 of 92 of 92 of 9
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--